{"bill":{"bill_id":1257746,"change_hash":"481a7a426753e5b754ec926a706d4470","session_id":1658,"session":{"session_id":1658,"state_id":52,"year_start":2019,"year_end":2020,"prefile":0,"sine_die":1,"prior":1,"special":0,"session_tag":"Regular Session","session_title":"2019-2020 Regular Session","session_name":"116th Congress"},"url":"https:\/\/legiscan.com\/US\/bill\/HB2580\/2019","state_link":"https:\/\/www.congress.gov\/bill\/116th-congress\/house-bill\/2580\/all-info","completed":0,"status":1,"status_date":"2019-05-08","progress":[{"date":"2019-05-08","event":1},{"date":"2019-05-08","event":9},{"date":"2019-05-08","event":9},{"date":"2019-05-09","event":9},{"date":"2019-05-31","event":9}],"state":"US","state_id":52,"bill_number":"HB2580","bill_type":"B","bill_type_id":"1","body":"H","body_id":114,"current_body":"H","current_body_id":114,"title":"Modernizing Drug Enforcement Act of 2019","description":"Deems a drug or substance that acts as an opioid mu receptor agonist (e.g., morphine) to be in schedule I of the Controlled Substances Act, subject to certain exceptions. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.","pending_committee_id":2349,"committee":{"committee_id":2349,"chamber":"H","chamber_id":114,"name":"Subcommittee on Crime, Terrorism, and Homeland Security"},"referrals":[{"date":"2019-05-08","committee_id":2302,"chamber":"H","chamber_id":114,"name":"Energy And Commerce"},{"date":"2019-05-09","committee_id":2355,"chamber":"H","chamber_id":114,"name":"Subcommittee on Health"},{"date":"2019-05-31","committee_id":2349,"chamber":"H","chamber_id":114,"name":"Subcommittee on Crime, Terrorism, and Homeland Security"}],"history":[{"date":"2019-05-08","action":"Introduced in House","chamber":"H","chamber_id":114,"importance":0},{"date":"2019-05-08","action":"Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.","chamber":"H","chamber_id":114,"importance":1},{"date":"2019-05-08","action":"Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.","chamber":"H","chamber_id":114,"importance":1},{"date":"2019-05-09","action":"Referred to the Subcommittee on Health.","chamber":"H","chamber_id":114,"importance":1},{"date":"2019-05-31","action":"Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.","chamber":"H","chamber_id":114,"importance":1}],"sponsors":[{"people_id":9315,"person_hash":"fcd7bhsu","party_id":"2","state_id":52,"party":"R","role_id":1,"role":"Rep","name":"David Roe","first_name":"David","middle_name":"P.","last_name":"Roe","suffix":"","nickname":"","district":"HD-TN-1","ftm_eid":2886736,"votesmart_id":65306,"opensecrets_id":"N00028463","knowwho_pid":267171,"ballotpedia":"Phil_Roe","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0},{"people_id":18333,"person_hash":"0akuuwt3","party_id":"1","state_id":52,"party":"D","role_id":1,"role":"Rep","name":"Thomas Suozzi","first_name":"Thomas","middle_name":"R.","last_name":"Suozzi","suffix":"","nickname":"","district":"HD-NY-3","ftm_eid":12996931,"votesmart_id":92111,"opensecrets_id":"N00038742","knowwho_pid":462663,"ballotpedia":"Tom_Suozzi","sponsor_type_id":2,"sponsor_order":2,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[],"subjects":[{"subject_id":13340,"subject_name":"Crime and law enforcement"},{"subject_id":13593,"subject_name":"Drug safety, medical device, and laboratory regulation"},{"subject_id":13345,"subject_name":"Drug trafficking and controlled substances"}],"texts":[{"doc_id":2019124,"date":"2019-05-15","type":"Introduced","type_id":1,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/US\/text\/HB2580\/id\/2019124","state_link":"https:\/\/www.congress.gov\/116\/bills\/hr2580\/BILLS-116hr2580ih.pdf","text_size":331318,"text_hash":"42cef29c424f9c8024b41dd8228db67e"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}